BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boukamp P. Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis 2005;26:1657-67. [PMID: 15905207 DOI: 10.1093/carcin/bgi123] [Cited by in Crossref: 230] [Cited by in F6Publishing: 200] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Nasti TH, Iqbal O, Tamimi IA, Geise JT, Katiyar SK, Yusuf N. Differential roles of T-cell subsets in regulation of ultraviolet radiation induced cutaneous photocarcinogenesis. Photochem Photobiol 2011;87:387-98. [PMID: 21143237 DOI: 10.1111/j.1751-1097.2010.00859.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
2 Fernandes AR, Santos AC, Sanchez-Lopez E, Kovačević AB, Espina M, Calpena AC, Veiga FJ, Garcia ML, Souto EB. Neoplastic Multifocal Skin Lesions: Biology, Etiology, and Targeted Therapies for Nonmelanoma Skin Cancers. Skin Pharmacol Physiol 2018;31:59-73. [PMID: 29262420 DOI: 10.1159/000479529] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
3 Surdu S. Non-melanoma skin cancer: occupational risk from UV light and arsenic exposure. Reviews on Environmental Health 2014;29. [DOI: 10.1515/reveh-2014-0040] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
4 Bellu E, Cruciani S, Garroni G, Balzano F, Satta R, Montesu MA, Fadda A, Mulas M, Sarais G, Bandiera P, Ventura C, Kralovič M, Sabo J, Amler E, Maioli M. Natural Compounds and PCL Nanofibers: A Novel Tool to Counteract Stem Cell Senescence. Cells 2021;10:1415. [PMID: 34200247 DOI: 10.3390/cells10061415] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Moloney FJ, Halliday GM. Nonmelanoma Skin Cancer. In: Gaspari AA, Tyring SK, editors. Clinical and Basic Immunodermatology. London: Springer; 2008. pp. 223-43. [DOI: 10.1007/978-1-84800-165-7_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Eckert RL, Adhikary G, Balasubramanian S, Rorke EA, Vemuri MC, Boucher SE, Bickenbach JR, Kerr C. Biochemistry of epidermal stem cells. Biochim Biophys Acta 2013;1830:2427-34. [PMID: 22820019 DOI: 10.1016/j.bbagen.2012.07.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
7 Toll A, Salgado R, Yébenes M, Martín-Ezquerra G, Gilaberte M, Baró T, Solé F, Alameda F, Espinet B, Pujol RM. Epidermal growth factor receptor gene numerical aberrations are frequent events in actinic keratoses and invasive cutaneous squamous cell carcinomas. Exp Dermatol. 2010;19:151-153. [PMID: 20156290 DOI: 10.1111/j.1600-0625.2009.01028.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
8 Meides A, Gutschalk CM, Devel L, Beau F, Czarny B, Hensler S, Neugebauer J, Dive V, Angel P, Mueller MM. Effects of selective MMP-13 inhibition in squamous cell carcinoma depend on estrogen. Int J Cancer 2014;135:2749-59. [PMID: 24676718 DOI: 10.1002/ijc.28866] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 South AP, O'Toole EA. Understanding the pathogenesis of recessive dystrophic epidermolysis bullosa squamous cell carcinoma. Dermatol Clin 2010;28:171-8. [PMID: 19945632 DOI: 10.1016/j.det.2009.10.023] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
10 Krynitz B, Olsson H, Lundh Rozell B, Lindelöf B, Edgren G, Smedby KE. Risk of basal cell carcinoma in Swedish organ transplant recipients: a population-based study. Br J Dermatol 2016;174:95-103. [PMID: 26333521 DOI: 10.1111/bjd.14153] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
11 Magcwebeba T, Swart P, Swanevelder S, Joubert E, Gelderblom W. Anti-Inflammatory Effects of Aspalathus linearis and Cyclopia spp. Extracts in a UVB/Keratinocyte (HaCaT) Model Utilising Interleukin-1α Accumulation as Biomarker. Molecules 2016;21:E1323. [PMID: 27706097 DOI: 10.3390/molecules21101323] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
12 Harwood CA, Proby CM, Cerio R. Appendageal Malignancies. In: Stockfleth E, Ulrich C, editors. Skin Cancer after Organ Transplantation. Boston: Springer US; 2009. pp. 353-74. [DOI: 10.1007/978-0-387-78574-5_29] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Van Overstraeten-Schlögel N, Ho-Shim Y, Tevel V, Bontems S, Dubois P, Raes M. Transfection of immortalized keratinocytes by low toxic poly(2-(dimethylamino)ethyl methacrylate)-based polymers. J Biomater Sci Polym Ed 2012;23:739-61. [PMID: 21396176 DOI: 10.1163/092050611X559430] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
14 Kwon SI, Chung YS, Kim YJ. Squamous cell carcinoma of the conjunctiva invading the orbit in a non-Hodgkin lymphoma. Jpn J Ophthalmol 2009;53:650-1. [PMID: 20020247 DOI: 10.1007/s10384-009-0733-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
15 Bailey HH, Kim K, Verma AK, Sielaff K, Larson PO, Snow S, Lenaghan T, Viner JL, Douglas J, Dreckschmidt NE, Hamielec M, Pomplun M, Sharata HH, Puchalsky D, Berg ER, Havighurst TC, Carbone PP. A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer. Cancer Prev Res (Phila) 2010;3:35-47. [PMID: 20051371 DOI: 10.1158/1940-6207.CAPR-09-0096] [Cited by in Crossref: 76] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
16 Hafner C, Landthaler M, Vogt T. Activation of the PI3K/AKT signalling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations: PIK3CA, AKT1 and non-melanoma skin cancer. Experimental Dermatology 2010;19:e222-7. [DOI: 10.1111/j.1600-0625.2009.01056.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
17 Peterson C, Moore R, Hicks JL, Morsberger LA, De Marzo AM, Zou Y, Eberhart CG, Campbell AA. NGS Analysis Confirms Common TP53 and RB1 Mutations, and Suggests MYC Amplification in Ocular Adnexal Sebaceous Carcinomas. Int J Mol Sci 2021;22:8454. [PMID: 34445161 DOI: 10.3390/ijms22168454] [Reference Citation Analysis]
18 Bzhalava Z, Hultin E, Dillner J. Extension of the viral ecology in humans using viral profile hidden Markov models. PLoS One 2018;13:e0190938. [PMID: 29351302 DOI: 10.1371/journal.pone.0190938] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
19 Gray SE, Kay E, Leader M, Mabruk M. Analysis of FHIT allelic imbalance/loss of heterozygosity and FHIT expression in cutaneous squamous cell carcinomas. Journal of Cutaneous Pathology 2008;35:816-25. [DOI: 10.1111/j.1600-0560.2007.00913.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
20 Rezvani HR, Cario-andré M, Pain C, Ged C, deVerneuil H, Taïeb A. Protection of normal human reconstructed epidermis from UV by catalase overexpression. Cancer Gene Ther 2007;14:174-86. [DOI: 10.1038/sj.cgt.7701000] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
21 Mamai O, Dodagatta-Marri E, Akhurst RJ. From prevention to cure, repurposing anti-viral vaccines for cancer immunotherapy. Biotarget 2018;2:20. [PMID: 30906919 DOI: 10.21037/biotarget.2018.12.03] [Reference Citation Analysis]
22 Reuschenbach M, Tran T, Faulstich F, Hartschuh W, Vinokurova S, Kloor M, Krautkrämer E, Zeier M, von Knebel Doeberitz M, Sommerer C. High-risk human papillomavirus in non-melanoma skin lesions from renal allograft recipients and immunocompetent patients. Br J Cancer 2011;104:1334-41. [PMID: 21427726 DOI: 10.1038/bjc.2011.95] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
23 Ribero S, Stucci LS, Daniels GA, Borradori L. Drug therapy of advanced cutaneous squamous cell carcinoma: is there any evidence? Curr Opin Oncol 2017;29:129-35. [PMID: 28151757 DOI: 10.1097/CCO.0000000000000359] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 3.4] [Reference Citation Analysis]
24 Kuivanen TT, Jeskanen L, Kyllönen L, Impola U, Saarialho-Kere UK. Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoacanthomas. Mod Pathol 2006;19:1203-12. [PMID: 16699496 DOI: 10.1038/modpathol.3800633] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
25 Tan MWY, Sng MK, Cheng HS, Low ZS, Leong BJJ, Chua D, Tan EHP, Chan JSK, Yip YS, Lee YH, Pal M, Wang X, Wahli W, Tan NS. Deficiency in fibroblast PPARβ/δ reduces nonmelanoma skin cancers in mice. Cell Death Differ 2020;27:2668-80. [PMID: 32313198 DOI: 10.1038/s41418-020-0535-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
26 Bellu E, Medici S, Coradduzza D, Cruciani S, Amler E, Maioli M. Nanomaterials in Skin Regeneration and Rejuvenation. Int J Mol Sci 2021;22:7095. [PMID: 34209468 DOI: 10.3390/ijms22137095] [Reference Citation Analysis]
27 Schmit TL, Zhong W, Nihal M, Ahmad N. Polo-like kinase 1 (Plk1) in non-melanoma skin cancers. Cell Cycle 2009;8:2697-702. [PMID: 19652546 DOI: 10.4161/cc.8.17.9413] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
28 Nappi A, Di Cicco E, Miro C, Cicatiello AG, Sagliocchi S, Mancino G, Ambrosio R, Luongo C, Di Girolamo D, De Stefano MA, Porcelli T, Stornaiuolo M, Dentice M. The NANOG Transcription Factor Induces Type 2 Deiodinase Expression and Regulates the Intracellular Activation of Thyroid Hormone in Keratinocyte Carcinomas. Cancers (Basel) 2020;12:E715. [PMID: 32197405 DOI: 10.3390/cancers12030715] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
29 Siljamäki E, Rappu P, Riihilä P, Nissinen L, Kähäri VM, Heino J. H-Ras activation and fibroblast-induced TGF-β signaling promote laminin-332 accumulation and invasion in cutaneous squamous cell carcinoma. Matrix Biol 2020;87:26-47. [PMID: 31655292 DOI: 10.1016/j.matbio.2019.09.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
30 Morandi EM, Rauchenwald T, Puelzl P, Zelger BW, Zelger BG, Henninger B, Pierer G, Wolfram D. Hide-and-seek: Neurotropic squamous cell carcinoma of the periorbital region - a series of five cases and review of the literature. J Dtsch Dermatol Ges 2021;19:1571-80. [PMID: 34811913 DOI: 10.1111/ddg.14582] [Reference Citation Analysis]
31 Linos K, Slominski A, Ross JS, Carlson JA. Melanoma update: diagnostic and prognostic factors that can effectively shape and personalize management. Biomark Med 2011;5:333-60. [PMID: 21657842 DOI: 10.2217/bmm.11.39] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
32 Katalinic D, Juretic A. Giant desmoplastic cutaneous squamous cell carcinoma of the gluteal region. World J Surg Oncol 2017;15:121. [PMID: 28676072 DOI: 10.1186/s12957-017-1191-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
33 Lazo de la Vega L, Bick N, Hu K, Rahrig SE, Silva CD, Matayoshi S, Picciarelli P, Wang X, Sugar A, Soong HK, Mian SI, Robinson DR, Chinnaiyan AM, Demirci H, Daniels AB, Worden F, Eberhart CG, Tomlins SA, Rao RC, Harms PW. Invasive squamous cell carcinomas and precursor lesions on UV-exposed epithelia demonstrate concordant genomic complexity in driver genes. Mod Pathol 2020;33:2280-94. [PMID: 32461624 DOI: 10.1038/s41379-020-0571-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
34 Stratigos A, Garbe C, Lebbe C, Malvehy J, del Marmol V, Pehamberger H, Peris K, Becker JC, Zalaudek I, Saiag P, Middleton MR, Bastholt L, Testori A, Grob J. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. European Journal of Cancer 2015;51:1989-2007. [DOI: 10.1016/j.ejca.2015.06.110] [Cited by in Crossref: 256] [Cited by in F6Publishing: 209] [Article Influence: 36.6] [Reference Citation Analysis]
35 Roh MR, Shin HJ, Lee SH, Chung KY. Risk of second cancers after the diagnosis of non-melanoma skin cancer in Korean patients: NMSC and risk of second primary cancers. The Journal of Dermatology 2012;39:541-4. [DOI: 10.1111/j.1346-8138.2011.01495.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
36 Pellegrini C, Maturo MG, Di Nardo L, Ciciarelli V, Gutiérrez García-Rodrigo C, Fargnoli MC. Understanding the Molecular Genetics of Basal Cell Carcinoma. Int J Mol Sci 2017;18:E2485. [PMID: 29165358 DOI: 10.3390/ijms18112485] [Cited by in Crossref: 74] [Cited by in F6Publishing: 54] [Article Influence: 14.8] [Reference Citation Analysis]
37 Williams VL, Cohen PR, Stewart DJ. Sorafenib-induced premalignant and malignant skin lesions. Int J Dermatol 2011;50:396-402. [PMID: 21413947 DOI: 10.1111/j.1365-4632.2010.04822.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
38 Chen AC, Halliday GM, Damian DL. Non-melanoma skin cancer: carcinogenesis and chemoprevention. Pathology 2013;45:331-41. [DOI: 10.1097/pat.0b013e32835f515c] [Cited by in Crossref: 66] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
39 Purdie KJ, Harwood CA, Gulati A, Chaplin T, Lambert SR, Cerio R, Kelly GP, Cazier JB, Young BD, Leigh IM, Proby CM. Single nucleotide polymorphism array analysis defines a specific genetic fingerprint for well-differentiated cutaneous SCCs. J Invest Dermatol 2009;129:1562-8. [PMID: 19131950 DOI: 10.1038/jid.2008.408] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
40 Kumar R, Deep G, Agarwal R. An Overview of Ultraviolet B Radiation-Induced Skin Cancer Chemoprevention by Silibinin. Curr Pharmacol Rep 2015;1:206-15. [PMID: 26097804 DOI: 10.1007/s40495-015-0027-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
41 Hameetman L, Commandeur S, Bavinck JN, Wisgerhof HC, de Gruijl FR, Willemze R, Mullenders L, Tensen CP, Vrieling H. Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients. BMC Cancer 2013;13:58. [PMID: 23379751 DOI: 10.1186/1471-2407-13-58] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 6.4] [Reference Citation Analysis]
42 Bugelski PJ, Volk A, Walker MR, Krayer JH, Martin P, Descotes J. Critical Review of Preclinical Approaches to Evaluate the Potential of Immunosuppressive Drugs to Influence Human Neoplasia. Int J Toxicol 2010;29:435-66. [DOI: 10.1177/1091581810374654] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
43 Peris K, Alaibac M, Argenziano G, Di Stefani A, Fargnoli MC, Frascione P, Gualdi G, Longo C, Moscarella E, Naldi L, Pellacani G, Pimpinelli N, Quaglino P, Salgarello M, Sollena P, Valentini V, Zalaudek I, Calzavara-pinton PG; on behalf of the Italian Group of Dermato-Oncology (GIDO) of SIDeMaST. Cutaneous squamous cell carcinoma. Italian Guidelines by SIDeMaST adapted to and updating EADO/EDF/EORTC guidelines. G Ital Dermatol Venereol 2018;153. [DOI: 10.23736/s0392-0488.18.06093-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
44 Ferreira SA, Vasconcelos JL, Silva RC, Cavalcanti CL, Bezerra CL, Rêgo MJ, Beltrão EI. Expression patterns of α2,3-sialyltransferase I and α2,6-sialyltransferase I in human cutaneous epithelial lesions. Eur J Histochem 2013;57:e7. [PMID: 23549466 DOI: 10.4081/ejh.2013.e7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
45 Lo BK, Yu M, Zloty D, Cowan B, Shapiro J, McElwee KJ. CXCR3/ligands are significantly involved in the tumorigenesis of basal cell carcinomas. Am J Pathol 2010;176:2435-46. [PMID: 20228225 DOI: 10.2353/ajpath.2010.081059] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 5.5] [Reference Citation Analysis]
46 Salavastru CM, Ulrich C, Cretu S, Moldovan HR, Tiplica GS. The experience of a tertiary referral centre in Romania on basal cell carcinomas in outdoor workers: why to assess? J Eur Acad Dermatol Venereol 2016;30 Suppl 3:12-6. [PMID: 26995017 DOI: 10.1111/jdv.13604] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
47 Justiniano R, Perer J, Hua A, Fazel M, Krajisnik A, Cabello CM, Wondrak GT. A Topical Zinc Ionophore Blocks Tumorigenic Progression in UV-exposed SKH-1 High-risk Mouse Skin. Photochem Photobiol 2017;93:1472-82. [PMID: 28503778 DOI: 10.1111/php.12794] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
48 Guan Y, Wang G, Fails D, Nagarajan P, Ge Y. Unraveling cancer lineage drivers in squamous cell carcinomas. Pharmacol Ther. 2020;206:107448. [PMID: 31836455 DOI: 10.1016/j.pharmthera.2019.107448] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
49 Mancha-Ramirez AM, Yang X, Liang H, Junco J, Lee KP, Bovio SF, Espinoza M, Wool J, Slaga A, Glade DC, Hanes M, Malik G, Kim DJ, DiGiovanni J, Slaga TJ. Harnessing the gatekeepers of glucocorticoids for chemoprevention of non-melanoma skin cancer. Mol Carcinog 2019;58:102-12. [PMID: 30302860 DOI: 10.1002/mc.22912] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
50 Nappi A, De Stefano MA, Dentice M, Salvatore D. Deiodinases and Cancer. Endocrinology 2021;162:bqab016. [PMID: 33539515 DOI: 10.1210/endocr/bqab016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
51 Reuschenbach M, Sommerer C, Hartschuh W, Zeier M, Doeberitz Mv, Kloor M. Absence of mismatch repair deficiency-related microsatellite instability in non-melanoma skin cancer. J Invest Dermatol 2012;132:491-3. [PMID: 22011909 DOI: 10.1038/jid.2011.326] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
52 Ogata D, Tsuchida T. Systemic Immunotherapy for Advanced Cutaneous Squamous Cell Carcinoma. Curr Treat Options Oncol 2019;20:30. [PMID: 30874952 DOI: 10.1007/s11864-019-0629-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
53 Naruke Y, Nakashima M, Suzuki K, Matsuu-matsuyama M, Shichijo K, Kondo H, Sekine I. Alteration of p53-binding protein 1 expression during skin carcinogenesis: Association with genomic instability. Cancer Science 2008;99:946-51. [DOI: 10.1111/j.1349-7006.2008.00786.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
54 Tan NS, Vázquez-Carrera M, Montagner A, Sng MK, Guillou H, Wahli W. Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ. Prog Lipid Res 2016;64:98-122. [PMID: 27665713 DOI: 10.1016/j.plipres.2016.09.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 6.5] [Reference Citation Analysis]
55 Meyer T. Molecular Pathogenesis of Basal Cell Carcinoma. In: Stockfleth E, Ulrich C, editors. Skin Cancer after Organ Transplantation. Boston: Springer US; 2009. pp. 193-204. [DOI: 10.1007/978-0-387-78574-5_17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
56 Patel GK, Yee CL, Terunuma A, Telford WG, Voong N, Yuspa SH, Vogel JC. Identification and characterization of tumor-initiating cells in human primary cutaneous squamous cell carcinoma. J Invest Dermatol 2012;132:401-9. [PMID: 22011906 DOI: 10.1038/jid.2011.317] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
57 Arroyo Mühr LS, Hortlund M, Bzhalava Z, Nordqvist Kleppe S, Bzhalava D, Hultin E, Dillner J. Viruses in case series of tumors: Consistent presence in different cancers in the same subject. PLoS One 2017;12:e0172308. [PMID: 28257474 DOI: 10.1371/journal.pone.0172308] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
58 Venza M, Catalano T, Visalli M, Venza I, Lentini M, Curia MC, Mariani-costantini R, Teti D. Association of the DSS1 c.143G>A Polymorphism with Skin Squamous Cell Carcinoma. Journal of Investigative Dermatology 2010;130:1719-25. [DOI: 10.1038/jid.2010.21] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
59 Stelkovics E, Korom I, Marczinovits I, Molnar J, Rasky K, Raso E, Ficsor L, Molnar B, Kopper L, Krenacs T. Collagen XVII/BP180 protein expression in squamous cell carcinoma of the skin detected with novel monoclonal antibodies in archived tissues using tissue microarrays and digital microscopy. Appl Immunohistochem Mol Morphol 2008;16:433-41. [PMID: 18633319 DOI: 10.1097/PAI.0b013e318162f8aa] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
60 Ju B, Spitsbergen J, Eden CJ, Taylor MR, Chen W. Co-activation of hedgehog and AKT pathways promote tumorigenesis in zebrafish. Mol Cancer 2009;8:40. [PMID: 19555497 DOI: 10.1186/1476-4598-8-40] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
61 Grun D, Adhikary G, Eckert RL. VEGF-A acts via neuropilin-1 to enhance epidermal cancer stem cell survival and formation of aggressive and highly vascularized tumors. Oncogene 2016;35:4379-87. [PMID: 26804163 DOI: 10.1038/onc.2015.507] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 6.8] [Reference Citation Analysis]
62 Samarasinghe V, Madan V, Lear JT. Management of high-risk squamous cell carcinoma of the skin. Expert Rev Anticancer Ther 2011;11:763-9. [PMID: 21554051 DOI: 10.1586/era.11.36] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
63 Li T, Qi Z, Kong F, Li Y, Wang R, Zhang W, Shang Y, Huang L, He D, Xiao X. S100A7 acts as a dual regulator in promoting proliferation and suppressing squamous differentiation through GATA-3/caspase-14 pathway in A431 cells. Exp Dermatol 2015;24:342-8. [PMID: 25651379 DOI: 10.1111/exd.12645] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
64 Gabet AS, Accardi R, Bellopede A, Popp S, Boukamp P, Sylla BS, Londoño-Vallejo JA, Tommasino M. Impairment of the telomere/telomerase system and genomic instability are associated with keratinocyte immortalization induced by the skin human papillomavirus type 38. FASEB J 2008;22:622-32. [PMID: 17898088 DOI: 10.1096/fj.07-8389com] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
65 Eilers M, Eisenman RN. Myc's broad reach. Genes Dev 2008;22:2755-66. [PMID: 18923074 DOI: 10.1101/gad.1712408] [Cited by in Crossref: 631] [Cited by in F6Publishing: 622] [Article Influence: 45.1] [Reference Citation Analysis]
66 Grealy R, Griffiths LR. Current status of pharmacogenomics testing for anti-tumor drug therapies: approaches to non-melanoma skin cancer. Mol Diagn Ther 2009;13:65-72. [PMID: 19537842 DOI: 10.1007/BF03256316] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
67 Burns EM, Tober KL, Riggenbach JA, Schick JS, Lamping KN, Kusewitt DF, Young GS, Oberyszyn TM. Preventative topical diclofenac treatment differentially decreases tumor burden in male and female Skh-1 mice in a model of UVB-induced cutaneous squamous cell carcinoma. Carcinogenesis 2013;34:370-7. [PMID: 23125227 DOI: 10.1093/carcin/bgs349] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
68 Roomi MW, Roomi NW, Kalinovsky T, Ivanov V, Rath M, Niedzwiecki A. Inhibition of 7,12-dimethylbenzanthracene-induced skin tumors by a nutrient mixture. Med Oncol 2008;25:333-40. [PMID: 18204975 DOI: 10.1007/s12032-008-9041-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
69 Lang CMR, Chan CK, Veltri A, Lien WH. Wnt Signaling Pathways in Keratinocyte Carcinomas. Cancers (Basel) 2019;11:E1216. [PMID: 31438551 DOI: 10.3390/cancers11091216] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
70 Rass K, Tilgen W. Treatment of melanoma and nonmelanoma skin cancer. Adv Exp Med Biol 2008;624:296-318. [PMID: 18348465 DOI: 10.1007/978-0-387-77574-6_23] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
71 Budden T, Bowden NA. The role of altered nucleotide excision repair and UVB-induced DNA damage in melanomagenesis. Int J Mol Sci 2013;14:1132-51. [PMID: 23303275 DOI: 10.3390/ijms14011132] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 6.1] [Reference Citation Analysis]
72 Kauvar AN, Cronin T Jr, Roenigk R, Hruza G, Bennett R; American Society for Dermatologic Surgery. Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods. Dermatol Surg 2015;41:550-71. [PMID: 25868035 DOI: 10.1097/DSS.0000000000000296] [Cited by in Crossref: 79] [Cited by in F6Publishing: 30] [Article Influence: 11.3] [Reference Citation Analysis]
73 Almomani R, Khanfar M, Bodoor K, Al-Qarqaz F, Alqudah M, Hammouri H, Abu-Salah A, Haddad Y, Al Gargaz W, Mohaidat Z. Evaluation of Patched-1 Protein Expression Level in Low Risk and High Risk Basal Cell Carcinoma Subtypes. Asian Pac J Cancer Prev 2019;20:2851-7. [PMID: 31554387 DOI: 10.31557/APJCP.2019.20.9.2851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
74 Alameda JP, Gaspar M, Ramírez Á, Navarro M, Page A, Suárez-Cabrera C, Fernández MG, Mérida JR, Paramio JM, García-Fernández RA, Fernández-Aceñero MJ, Casanova ML. Deciphering the role of nuclear and cytoplasmic IKKα in skin cancer. Oncotarget 2016;7:29531-47. [PMID: 27121058 DOI: 10.18632/oncotarget.8792] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
75 Simka M. Do nonmelanoma skin cancers develop from extra-cutaneous stem cells? Int J Cancer 2008;122:2173-7. [PMID: 18240148 DOI: 10.1002/ijc.23373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
76 Ventura A, Pellegrini C, Cardelli L, Rocco T, Ciciarelli V, Peris K, Fargnoli MC. Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma. Int J Mol Sci 2019;20:E1333. [PMID: 30884806 DOI: 10.3390/ijms20061333] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
77 Samarasinghe V, Madan V. Nonmelanoma skin cancer. J Cutan Aesthet Surg 2012;5:3-10. [PMID: 22557848 DOI: 10.4103/0974-2077.94323] [Cited by in Crossref: 92] [Cited by in F6Publishing: 75] [Article Influence: 9.2] [Reference Citation Analysis]
78 Fidrus E, Hegedűs C, Janka EA, Paragh G, Emri G, Remenyik É. Inhibitors of Nucleotide Excision Repair Decrease UVB-Induced Mutagenesis-An In Vitro Study. Int J Mol Sci 2021;22:1638. [PMID: 33562002 DOI: 10.3390/ijms22041638] [Reference Citation Analysis]
79 Arroyo Mühr LS, Hultin E, Bzhalava D, Eklund C, Lagheden C, Ekström J, Johansson H, Forslund O, Dillner J. Human papillomavirus type 197 is commonly present in skin tumors: HPV in skin tumors. Int J Cancer 2015;136:2546-55. [DOI: 10.1002/ijc.29325] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 5.5] [Reference Citation Analysis]
80 Starrett GJ, Marcelus C, Cantalupo PG, Katz JP, Cheng J, Akagi K, Thakuria M, Rabinowits G, Wang LC, Symer DE, Pipas JM, Harris RS, DeCaprio JA. Merkel Cell Polyomavirus Exhibits Dominant Control of the Tumor Genome and Transcriptome in Virus-Associated Merkel Cell Carcinoma. mBio 2017;8:e02079-16. [PMID: 28049147 DOI: 10.1128/mBio.02079-16] [Cited by in Crossref: 63] [Cited by in F6Publishing: 42] [Article Influence: 12.6] [Reference Citation Analysis]
81 Burnworth B, Arendt S, Muffler S, Steinkraus V, Bröcker EB, Birek C, Hartschuh W, Jauch A, Boukamp P. The multi-step process of human skin carcinogenesis: A role for p53, cyclin D1, hTERT, p16, and TSP-1. European Journal of Cell Biology 2007;86:763-80. [DOI: 10.1016/j.ejcb.2006.11.002] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
82 Xie J. Molecular biology of basal and squamous cell carcinomas. Adv Exp Med Biol 2008;624:241-51. [PMID: 18348461 DOI: 10.1007/978-0-387-77574-6_19] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
83 Paul J, Carlson JA. Lymphangiectases Are Common Underlying Warts and in Normal Peritumoral Skin: Histologic Evidence of Decreased Immune Surveillance. The American Journal of Dermatopathology 2011;33:152-60. [DOI: 10.1097/dad.0b013e3181ef2d65] [Cited by in Crossref: 21] [Cited by in F6Publishing: 2] [Article Influence: 1.9] [Reference Citation Analysis]
84 Cheepala SB, Yin W, Syed Z, Gill JN, McMillian A, Kleiner HE, Lynch M, Loganantharaj R, Trutschl M, Cvek U. Identification of the B-Raf/Mek/Erk MAP kinase pathway as a target for all-trans retinoic acid during skin cancer promotion. Mol Cancer. 2009;8:27. [PMID: 19432991 DOI: 10.1186/1476-4598-8-27] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
85 Lemarie A, Morzadec C, Bourdonnay E, Fardel O, Vernhet L. Human Macrophages Constitute Targets for Immunotoxic Inorganic Arsenic. J Immunol 2006;177:3019-27. [DOI: 10.4049/jimmunol.177.5.3019] [Cited by in Crossref: 97] [Cited by in F6Publishing: 89] [Article Influence: 6.1] [Reference Citation Analysis]
86 Paulitschke V, Gerner C, Hofstätter E, Mohr T, Mayer RL, Pehamberger H, Kunstfeld R. Proteome profiling of keratinocytes transforming to malignancy. Electrophoresis 2015;36:564-76. [PMID: 25395074 DOI: 10.1002/elps.201400309] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
87 Tampa M, Nicolae I, Mitran CI, Mitran MI, Ene C, Matei C, Georgescu SR, Ene CD. Serum Sialylation Changes in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Patients. J Pers Med 2021;11:1027. [PMID: 34683168 DOI: 10.3390/jpm11101027] [Reference Citation Analysis]
88 Freytag J, Wilkins-Port CE, Higgins CE, Carlson JA, Noel A, Foidart JM, Higgins SP, Samarakoon R, Higgins PJ. PAI-1 Regulates the Invasive Phenotype in Human Cutaneous Squamous Cell Carcinoma. J Oncol 2009;2009:963209. [PMID: 20204159 DOI: 10.1155/2009/963209] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
89 Koehn J, Krapfenbauer K, Huber S, Stein E, Sutter W, Watzinger F, Erovic BM, Thurnher D, Schindler T, Fountoulakis M, Turhani D. Potential Involvement of MYC- and p53-Related Pathways in Tumorigenesis in Human Oral Squamous Cell Carcinoma Revealed by Proteomic Analysis. J Proteome Res 2008;7:3818-29. [DOI: 10.1021/pr800077a] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
90 Belum VR, Fischer A, Choi JN, Lacouture ME. Dermatological adverse events from BRAF inhibitors: a growing problem. Curr Oncol Rep 2013;15:249-59. [PMID: 23463215 DOI: 10.1007/s11912-013-0308-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
91 Brauchle E, Johannsen H, Nolan S, Thude S, Schenke-Layland K. Design and analysis of a squamous cell carcinoma in vitro model system. Biomaterials 2013;34:7401-7. [PMID: 23827189 DOI: 10.1016/j.biomaterials.2013.06.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
92 Langley RG, Papp K, Gottlieb AB, Krueger GG, Gordon KB, Williams D, Valdes J, Setze C, Strober B. Safety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open-label extension trial of the interleukin-12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasis. J Eur Acad Dermatol Venereol 2013;27:1252-61. [PMID: 23157612 DOI: 10.1111/j.1468-3083.2012.04705.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
93 Chen P, Liu T, Wang D, Zhang Q, Hu L. Modified Vinyl–POSS Materials as Sun Protection Factor and as Films for Greenhouse Cover. Ferroelectrics 2010;411:36-43. [DOI: 10.1080/00150193.2010.493074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
94 Pavlova O, Lefort K, Mariotto A, Huber M, Hohl D. HOPX Exhibits Oncogenic Activity during Squamous Skin Carcinogenesis. J Invest Dermatol 2021:S0022-202X(21)01131-3. [PMID: 33845078 DOI: 10.1016/j.jid.2020.04.034] [Reference Citation Analysis]
95 Burns EM, Guroji P, Ahmad I, Nasr HM, Wang Y, Tamimi IA, Stiefel E, Abdelgawwad MS, Shaheen A, Muzaffar AF, Bush LM, Hurst CB, Griffin RL, Elmets CA, Yusuf N. Association of Vitamin D Receptor Polymorphisms With the Risk of Nonmelanoma Skin Cancer in Adults. JAMA Dermatol 2017;153:983-9. [PMID: 28832880 DOI: 10.1001/jamadermatol.2017.1976] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
96 Bailey K, Xia Y, Ward WO, Knapp G, Mo J, Mumford JL, Owen RD, Thai S. Global Gene Expression Profiling of Hyperkeratotic Skin Lesions from Inner Mongolians Chronically Exposed to Arsenic. Toxicol Pathol 2009;37:849-59. [DOI: 10.1177/0192623309351725] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
97 Bzhalava D, Johansson H, Ekström J, Faust H, Möller B, Eklund C, Nordin P, Stenquist B, Paoli J, Persson B, Forslund O, Dillner J. Unbiased approach for virus detection in skin lesions. PLoS One 2013;8:e65953. [PMID: 23840382 DOI: 10.1371/journal.pone.0065953] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
98 Darido C, Georgy SR, Cullinane C, Partridge DD, Walker R, Srivastava S, Roslan S, Carpinelli MR, Dworkin S, Pearson RB, Jane SM. Stage-dependent therapeutic efficacy in PI3K/mTOR-driven squamous cell carcinoma of the skin. Cell Death Differ 2018;25:1146-59. [PMID: 29238073 DOI: 10.1038/s41418-017-0032-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
99 Muthusamy V, Piva TJ. A comparative study of UV-induced cell signalling pathways in human keratinocyte-derived cell lines. Arch Dermatol Res 2013;305:817-33. [PMID: 24071771 DOI: 10.1007/s00403-013-1412-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
100 Dworkin AM, Tober KL, Duncan FJ, Yu L, VanBuskirk AM, Oberyszyn TM, Toland AE. Chromosomal aberrations in UVB-induced tumors of immunosuppressed mice. Genes Chromosomes Cancer 2009;48:490-501. [PMID: 19296524 DOI: 10.1002/gcc.20657] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
101 Caulin C, Nguyen T, Lang GA, Goepfert TM, Brinkley BR, Cai WW, Lozano G, Roop DR. An inducible mouse model for skin cancer reveals distinct roles for gain- and loss-of-function p53 mutations. J Clin Invest 2007;117:1893-901. [PMID: 17607363 DOI: 10.1172/JCI31721] [Cited by in Crossref: 96] [Cited by in F6Publishing: 59] [Article Influence: 6.4] [Reference Citation Analysis]
102 Chen J, Ruczinski I, Jorgensen TJ, Yenokyan G, Yao Y, Alani R, Liégeois NJ, Hoffman SC, Hoffman-Bolton J, Strickland PT, Helzlsouer KJ, Alberg AJ. Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst 2008;100:1215-22. [PMID: 18728282 DOI: 10.1093/jnci/djn260] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 6.1] [Reference Citation Analysis]
103 Wei HP, Zhan S, Zhu QA, Chen ZJ, Feng X, Chen JY, Zhang QL, Zhao J, Meng L. Genome-Wide Expression Difference of MicroRNAs in Basal Cell Carcinoma. J Immunol Res 2021;2021:7223500. [PMID: 34395634 DOI: 10.1155/2021/7223500] [Reference Citation Analysis]
104 Ratushny V, Gober MD, Hick R, Ridky TW, Seykora JT. From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest. 2012;122:464-472. [PMID: 22293185 DOI: 10.1172/jci57415] [Cited by in Crossref: 309] [Cited by in F6Publishing: 146] [Article Influence: 30.9] [Reference Citation Analysis]
105 Pérez-Lorenzo R, Zheng B. Targeted inhibition of BRAF kinase: opportunities and challenges for therapeutics in melanoma. Biosci Rep 2012;32:25-33. [PMID: 21981139 DOI: 10.1042/BSR20110068] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
106 Cabral LS, Festa Neto C, Sanches JA Jr, Ruiz IR. Genomic instability in human actinic keratosis and squamous cell carcinoma. Clinics (Sao Paulo) 2011;66:523-8. [PMID: 21655741 DOI: 10.1590/s1807-59322011000400001] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
107 Oberyszyn TM. Non-melanoma skin cancer: Importance of gender, immunosuppressive status and vitamin D. Cancer Letters 2008;261:127-36. [DOI: 10.1016/j.canlet.2008.01.009] [Cited by in Crossref: 63] [Cited by in F6Publishing: 55] [Article Influence: 4.5] [Reference Citation Analysis]
108 Ly E, Piot O, Durlach A, Bernard P, Manfait M. Differential diagnosis of cutaneous carcinomas by infrared spectral micro-imaging combined with pattern recognition. Analyst 2009;134:1208. [DOI: 10.1039/b820998g] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
109 Morandi EM, Rauchenwald T, Puelzl P, Zelger BW, Zelger BG, Henninger B, Pierer G, Wolfram D. Hide-and-seek: Neurotropes Plattenepithelkarzinom der periorbitalen Region - eine Fallserie und Übersichtsarbeit aktueller Literatur. J Dtsch Dermatol Ges 2021;19:1571-81. [PMID: 34811899 DOI: 10.1111/ddg.14582_g] [Reference Citation Analysis]
110 Toll A, Salgado R, Yébenes M, Martín-ezquerra G, Gilaberte M, Baró T, Solé F, Alameda F, Espinet B, Pujol R. MYC gene numerical aberrations in actinic keratosis and cutaneous squamous cell carcinoma. British Journal of Dermatology 2009;161:1112-8. [DOI: 10.1111/j.1365-2133.2009.09351.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
111 Tchernev G, Wollina U. Pathways of tumor development and progression in drug-induced nonmelanoma skin cancer: a new hope or the next great confusion? Wien Med Wochenschr 2014;164:286-95. [PMID: 24723125 DOI: 10.1007/s10354-014-0271-3] [Reference Citation Analysis]
112 Ahmed AH, Soyer HP, Saunders N, Boukamp P, Roberts MS. Non-melanoma skin cancers. Drug Discovery Today: Disease Mechanisms 2008;5:e55-62. [DOI: 10.1016/j.ddmec.2008.05.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
113 Alonso-Lecue P, de Pedro I, Coulon V, Molinuevo R, Lorz C, Segrelles C, Ceballos L, López-Aventín D, García-Valtuille A, Bernal JM, Mazorra F, Pujol RM, Paramio J, Ramón Sanz J, Freije A, Toll A, Gandarillas A. Inefficient differentiation response to cell cycle stress leads to genomic instability and malignant progression of squamous carcinoma cells. Cell Death Dis 2017;8:e2901. [PMID: 28661481 DOI: 10.1038/cddis.2017.259] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
114 Harradine KA, Ridd K, Saunier EF, Clermont FF, Perez-Losada J, Moore DH, Epstein EH Jr, Bastian BC, Akhurst RJ. Elevated cutaneous Smad activation associates with enhanced skin tumor susceptibility in organ transplant recipients. Clin Cancer Res 2009;15:5101-7. [PMID: 19671862 DOI: 10.1158/1078-0432.CCR-08-3286] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
115 de Pedro I, Alonso-Lecue P, Sanz-Gómez N, Freije A, Gandarillas A. Sublethal UV irradiation induces squamous differentiation via a p53-independent, DNA damage-mitosis checkpoint. Cell Death Dis 2018;9:1094. [PMID: 30361544 DOI: 10.1038/s41419-018-1130-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
116 Kovanda A, Kocjan BJ, Luzar B, Bravo IG, Poljak M. Characterization of novel cutaneous human papillomavirus genotypes HPV-150 and HPV-151. PLoS One 2011;6:e22529. [PMID: 21799888 DOI: 10.1371/journal.pone.0022529] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
117 Mueller MM. Inflammation in epithelial skin tumours: old stories and new ideas. Eur J Cancer 2006;42:735-44. [PMID: 16527478 DOI: 10.1016/j.ejca.2006.01.014] [Cited by in Crossref: 119] [Cited by in F6Publishing: 100] [Article Influence: 7.4] [Reference Citation Analysis]
118 Mattei P, Alora-palli M, Kraft S, Lawrence D, Flaherty K, Kimball A. Cutaneous effects of BRAF inhibitor therapy: a case series. Annals of Oncology 2013;24:530-7. [DOI: 10.1093/annonc/mds292] [Cited by in Crossref: 60] [Cited by in F6Publishing: 44] [Article Influence: 6.7] [Reference Citation Analysis]
119 Sand M, Bechara FG, Gambichler T, Sand D, Friedländer MR, Bromba M, Schnabel R, Hessam S. Next-generation sequencing of the basal cell carcinoma miRNome and a description of novel microRNA candidates under neoadjuvant vismodegib therapy: an integrative molecular and surgical case study. Ann Oncol 2016;27:332-8. [PMID: 26578727 DOI: 10.1093/annonc/mdv551] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
120 Ekström J, Bzhalava D, Svenback D, Forslund O, Dillner J. High throughput sequencing reveals diversity of Human Papillomaviruses in cutaneous lesions. Int J Cancer 2011;129:2643-50. [PMID: 21630257 DOI: 10.1002/ijc.26204] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 5.5] [Reference Citation Analysis]
121 Del Piccolo N, Shirure VS, Bi Y, Goedegebuure SP, Gholami S, Hughes CCW, Fields RC, George SC. Tumor-on-chip modeling of organ-specific cancer and metastasis. Adv Drug Deliv Rev 2021;175:113798. [PMID: 34015419 DOI: 10.1016/j.addr.2021.05.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
122 Rodust PM, Stockfleth E, Ulrich C, Leverkus M, Eberle J. UV-induced squamous cell carcinoma--a role for antiapoptotic signalling pathways. Br J Dermatol 2009;161 Suppl 3:107-15. [PMID: 19775366 DOI: 10.1111/j.1365-2133.2009.09458.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 4.9] [Reference Citation Analysis]
123 Surdu S, Fitzgerald EF, Bloom MS, Boscoe FP, Carpenter DO, Haase RF, Gurzau E, Rudnai P, Koppova K, Févotte J, Leonardi G, Vahter M, Goessler W, Kumar R, Fletcher T. Occupational exposure to ultraviolet radiation and risk of non-melanoma skin cancer in a multinational European study. PLoS One 2013;8:e62359. [PMID: 23638051 DOI: 10.1371/journal.pone.0062359] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
124 Mishra AK, Kadoishi T, Wang X, Driver E, Chen Z, Wang XJ, Wang JH. Squamous cell carcinomas escape immune surveillance via inducing chronic activation and exhaustion of CD8+ T Cells co-expressing PD-1 and LAG-3 inhibitory receptors. Oncotarget 2016;7:81341-56. [PMID: 27835902 DOI: 10.18632/oncotarget.13228] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 9.5] [Reference Citation Analysis]
125 Zhang X, Wu L, Xiao T, Tang L, Jia X, Guo Y, Zhang J, Li J, He Y, Su J, Zhao S, Tao J, Zhou J, Chen X, Peng C. TRAF6 regulates EGF-induced cell transformation and cSCC malignant phenotype through CD147/EGFR. Oncogenesis 2018;7:17. [PMID: 29463844 DOI: 10.1038/s41389-018-0030-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
126 Kraemer A, Chen IP, Henning S, Faust A, Volkmer B, Atkinson MJ, Moertl S, Greinert R. UVA and UVB irradiation differentially regulate microRNA expression in human primary keratinocytes. PLoS One 2013;8:e83392. [PMID: 24391759 DOI: 10.1371/journal.pone.0083392] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 4.2] [Reference Citation Analysis]
127 Watt FM, Frye M, Benitah SA. MYC in mammalian epidermis: how can an oncogene stimulate differentiation? Nat Rev Cancer 2008;8:234-42. [PMID: 18292777 DOI: 10.1038/nrc2328] [Cited by in Crossref: 106] [Cited by in F6Publishing: 104] [Article Influence: 7.6] [Reference Citation Analysis]
128 Mizrahi A, Barzilai A, Gur-Wahnon D, Ben-Dov IZ, Glassberg S, Meningher T, Elharar E, Masalha M, Jacob-Hirsch J, Tabibian-Keissar H, Barshack I, Roszik J, Leibowitz-Amit R, Sidi Y, Avni D. Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma: the role of miR-497 in epithelial to mesenchymal transition of keratinocytes. Oncogene 2018;37:218-30. [PMID: 28925390 DOI: 10.1038/onc.2017.315] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
129 Al Rawashdeh W, Arns S, Gremse F, Ehling J, Knüchel-Clarke R, Kray S, Spöler F, Kiessling F, Lederle W. Optical tomography of MMP activity allows a sensitive noninvasive characterization of the invasiveness and angiogenesis of SCC xenografts. Neoplasia. 2014;16:235-246, 246.e1. [PMID: 24784000 DOI: 10.1016/j.neo.2014.03.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
130 Wainstein AJA, Oliveira TAD, Guelfi DCF, Gontijo BR, Castro EVD, Carvalho RAD, Paz NM, Lacerda LT. Amputação de membros por carcinoma escamocelular da pele: fatores envolvidos nesta evolução desfavorável. Rev Col Bras Cir 2012;39:173-7. [DOI: 10.1590/s0100-69912012000300002] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
131 Wenzel J, Tormo D, Tüting T. Toll-like receptor-agonists in the treatment of skin cancer: history, current developments and future prospects. Handb Exp Pharmacol 2008;:201-20. [PMID: 18071661 DOI: 10.1007/978-3-540-72167-3_10] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
132 Young LC, Listgarten J, Trotter MJ, Andrew SE, Tron VA. Evidence that dysregulated DNA mismatch repair characterizes human nonmelanoma skin cancer. Br J Dermatol 2008;158:59-69. [PMID: 17970804 DOI: 10.1111/j.1365-2133.2007.08249.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
133 Adnot-Desanlis L, Bernard P, Reguiaï Z. [Squamous cell carcinoma in a patient receiving sorafenib]. Ann Dermatol Venereol 2011;138:120-3. [PMID: 21333823 DOI: 10.1016/j.annder.2010.04.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
134 Prado R, Francis SO, Mason MN, Wing G, Gamble RG, Dellavalle R. Nonmelanoma skin cancer chemoprevention. Dermatol Surg 2011;37:1566-78. [PMID: 21895847 DOI: 10.1111/j.1524-4725.2011.02108.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
135 Moubayed N, Weichenthal M, Harder J, Wandel E, Sticherling M, Gläser R. Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours. J Cancer Res Clin Oncol. 2007;133:253-261. [PMID: 17136347 DOI: 10.1007/s00432-006-0164-y] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
136 Megyeri K, Orosz L, Kemény L. Vesicular stomatitis virus infection triggers apoptosis associated with decreased DeltaNp63alpha and increased Bax levels in the immortalized HaCaT keratinocyte cell line. Biomed Pharmacother 2007;61:254-60. [PMID: 17459650 DOI: 10.1016/j.biopha.2007.03.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
137 Oskarsson T, Essers MA, Dubois N, Offner S, Dubey C, Roger C, Metzger D, Chambon P, Hummler E, Beard P, Trumpp A. Skin epidermis lacking the c-Myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene. Genes Dev 2006;20:2024-9. [PMID: 16882980 DOI: 10.1101/gad.381206] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 3.8] [Reference Citation Analysis]
138 Di Cicco E, Moran C, Visser WE, Nappi A, Schoenmakers E, Todd P, Lyons G, Dattani M, Ambrosio R, Parisi S, Salvatore D, Chatterjee K, Dentice M. Germ Line Mutations in the Thyroid Hormone Receptor Alpha Gene Predispose to Cutaneous Tags and Melanocytic Nevi. Thyroid 2021;31:1114-26. [PMID: 33509032 DOI: 10.1089/thy.2020.0391] [Reference Citation Analysis]
139 Riihilä P, Nissinen L, Kähäri VM. Matrix metalloproteinases in keratinocyte carcinomas. Exp Dermatol 2021;30:50-61. [PMID: 32869366 DOI: 10.1111/exd.14183] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
140 Guenther LC, Barber K, Searles GE, Lynde CW, Janiszewski P, Ashkenas J; Canadian Non-melanoma Skin Cancer Guidelines Committee. Non-melanoma Skin Cancer in Canada Chapter 1: Introduction to the Guidelines. J Cutan Med Surg 2015;19:205-15. [PMID: 26016676 DOI: 10.1177/1203475415588652] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
141 Lukowski SW, Tuong ZK, Noske K, Senabouth A, Nguyen QH, Andersen SB, Soyer HP, Frazer IH, Powell JE. Detection of HPV E7 Transcription at Single-Cell Resolution in Epidermis. Journal of Investigative Dermatology 2018;138:2558-67. [DOI: 10.1016/j.jid.2018.06.169] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
142 Darido C, Georgy SR, Wilanowski T, Dworkin S, Auden A, Zhao Q, Rank G, Srivastava S, Finlay MJ, Papenfuss AT, Pandolfi PP, Pearson RB, Jane SM. Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis. Cancer Cell. 2011;20:635-648. [PMID: 22094257 DOI: 10.1016/j.ccr.2011.10.014] [Cited by in Crossref: 148] [Cited by in F6Publishing: 149] [Article Influence: 14.8] [Reference Citation Analysis]
143 Magee BH, Forsberg ND. Testing the validity of a proposed dermal cancer slope factor for Benzo[a]pyrene. Regul Toxicol Pharmacol 2021;120:104852. [PMID: 33359623 DOI: 10.1016/j.yrtph.2020.104852] [Reference Citation Analysis]
144 Josiah AJ, Twilley D, Pillai SK, Ray SS, Lall N. Pathogenesis of Keratinocyte Carcinomas and the Therapeutic Potential of Medicinal Plants and Phytochemicals. Molecules 2021;26:1979. [PMID: 33915735 DOI: 10.3390/molecules26071979] [Reference Citation Analysis]
145 Masoumi KC, Shaw-Hallgren G, Massoumi R. Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer. J Skin Cancer 2011;2011:614097. [PMID: 22235375 DOI: 10.1155/2011/614097] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
146 Fortina AB, Piaserico S, Alaibac M, Peserico A. Squamous cell carcinoma. Cancer Treat Res 2009;146:241-61. [PMID: 19415208 DOI: 10.1007/978-0-387-78574-5_21] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
147 Luo JD, Hu TP, Wang L, Chen MS, Liu SM, Chen AF. Sonic hedgehog improves delayed wound healing via enhancing cutaneous nitric oxide function in diabetes. Am J Physiol Endocrinol Metab 2009;297:E525-31. [PMID: 19531636 DOI: 10.1152/ajpendo.00308.2009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
148 Liu-Smith F, Jia J, Zheng Y. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer. Adv Exp Med Biol 2017;996:27-40. [PMID: 29124688 DOI: 10.1007/978-3-319-56017-5_3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 9.8] [Reference Citation Analysis]
149 Lee S, Chari NS, Kim HW, Wang X, Roop DR, Cho SH, DiGiovanni J, McDonnell TJ. Cooperation of Ha-ras and Bcl-2 during multistep skin carcinogenesis. Mol Carcinog 2007;46:949-57. [PMID: 17538944 DOI: 10.1002/mc.20334] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
150 Veness MJ, Kian Ang K. Cutaneous Carcinoma. Clinical Radiation Oncology. Elsevier; 2012. pp. 757-69. [DOI: 10.1016/b978-1-4377-1637-5.00039-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
151 Vieira RAMAR, Minicucci EM, Marques MEA, Marques SA. Actinic cheilitis and squamous cell carcinoma of the lip: clinical, histopathological and immunogenetic aspects. An Bras Dermatol 2012;87:105-14. [DOI: 10.1590/s0365-05962012000100013] [Cited by in Crossref: 59] [Cited by in F6Publishing: 18] [Article Influence: 5.9] [Reference Citation Analysis]
152 Pavez Lorie E, Stricker N, Plitta-Michalak B, Chen IP, Volkmer B, Greinert R, Jauch A, Boukamp P, Rapp A. Characterisation of the novel spontaneously immortalized and invasively growing human skin keratinocyte line HaSKpw. Sci Rep 2020;10:15196. [PMID: 32938951 DOI: 10.1038/s41598-020-71315-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
153 Gandarillas A. The mysterious human epidermal cell cycle, or an oncogene-induced differentiation checkpoint. Cell Cycle 2012;11:4507-16. [PMID: 23114621 DOI: 10.4161/cc.22529] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
154 Leverkus M, Diessenbacher P, Geserick P. FLIP ing the coin? Death receptor-mediated signals during skin tumorigenesis. Exp Dermatol 2008;17:614-22. [PMID: 18558995 DOI: 10.1111/j.1600-0625.2008.00728.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
155 Leufke C, Leykauf J, Krunic D, Jauch A, Holtgreve-grez H, Böhm-steuer B, Bröcker E, Mauch C, Utikal J, Hartschuh W, Purdie KJ, Boukamp P. The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomas. Oncogene 2014;33:3506-18. [DOI: 10.1038/onc.2013.323] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
156 De Blasio C, Verma N, Moretti M, Cialfi S, Zonfrilli A, Franchitto M, Truglio F, De Smaele E, Ichijo H, Naguro I, Screpanti I, Talora C. Functional cooperation between ASK1 and p21Waf1/Cip1 in the balance of cell-cycle arrest, cell death and tumorigenesis of stressed keratinocytes. Cell Death Discov 2021;7:75. [PMID: 33846306 DOI: 10.1038/s41420-021-00459-3] [Reference Citation Analysis]
157 Wu X, Nguyen BC, Dziunycz P, Chang S, Brooks Y, Lefort K, Hofbauer GF, Dotto GP. Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature. 2010;465:368-372. [PMID: 20485437 DOI: 10.1038/nature08996] [Cited by in Crossref: 198] [Cited by in F6Publishing: 181] [Article Influence: 16.5] [Reference Citation Analysis]
158 Sand M, Bechara FG, Sand D, Gambichler T, Hahn SA, Bromba M, Stockfleth E, Hessam S. Circular RNA expression in basal cell carcinoma. Epigenomics 2016;8:619-32. [DOI: 10.2217/epi-2015-0019] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 10.2] [Reference Citation Analysis]
159 Nindl I, Rösl F. Molecular Pathogenesis of Squamous Cell Carcinoma. In: Stockfleth E, Ulrich C, editors. Skin Cancer after Organ Transplantation. Boston: Springer US; 2009. pp. 205-11. [DOI: 10.1007/978-0-387-78574-5_18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
160 Montagner A, Delgado MB, Tallichet-Blanc C, Chan JS, Sng MK, Mottaz H, Degueurce G, Lippi Y, Moret C, Baruchet M, Antsiferova M, Werner S, Hohl D, Saati TA, Farmer PJ, Tan NS, Michalik L, Wahli W. Src is activated by the nuclear receptor peroxisome proliferator-activated receptor β/δ in ultraviolet radiation-induced skin cancer. EMBO Mol Med 2014;6:80-98. [PMID: 24203162 DOI: 10.1002/emmm.201302666] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
161 Kassem A, Technau K, Kurz AK, Pantulu D, Löning M, Kayser G, Stickeler E, Weyers W, Diaz C, Werner M, Nashan D, Zur Hausen A. Merkel cell polyomavirus sequences are frequently detected in nonmelanoma skin cancer of immunosuppressed patients. Int J Cancer 2009;125:356-61. [PMID: 19384948 DOI: 10.1002/ijc.24323] [Cited by in Crossref: 105] [Cited by in F6Publishing: 99] [Article Influence: 8.1] [Reference Citation Analysis]
162 Torchia EC, Caulin C, Acin S, Terzian T, Kubick BJ, Box NF, Roop DR. Myc, Aurora Kinase A, and mutant p53(R172H) co-operate in a mouse model of metastatic skin carcinoma. Oncogene 2012;31:2680-90. [PMID: 21963848 DOI: 10.1038/onc.2011.441] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
163 Vasiljević N, Hazard K, Dillner J, Forslund O. Four novel human betapapillomaviruses of species 2 preferentially found in actinic keratosis. Journal of General Virology 2008;89:2467-74. [DOI: 10.1099/vir.0.2008/001925-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.0] [Reference Citation Analysis]
164 Boehnke K, Falkowska-Hansen B, Stark HJ, Boukamp P. Stem cells of the human epidermis and their niche: composition and function in epidermal regeneration and carcinogenesis. Carcinogenesis 2012;33:1247-58. [PMID: 22461521 DOI: 10.1093/carcin/bgs136] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
165 Bzhalava D, Guan P, Franceschi S, Dillner J, Clifford G. A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types. Virology 2013;445:224-31. [PMID: 23928291 DOI: 10.1016/j.virol.2013.07.015] [Cited by in Crossref: 160] [Cited by in F6Publishing: 148] [Article Influence: 17.8] [Reference Citation Analysis]
166 Serçin Ö, Larsimont J, Karambelas AE, Marthiens V, Moers V, Boeckx B, Le Mercier M, Lambrechts D, Basto R, Blanpain C. Transient PLK4 overexpression accelerates tumorigenesis in p53-deficient epidermis. Nat Cell Biol 2016;18:100-10. [DOI: 10.1038/ncb3270] [Cited by in Crossref: 102] [Cited by in F6Publishing: 86] [Article Influence: 14.6] [Reference Citation Analysis]
167 Chen IP, Henning S, Faust A, Boukamp P, Volkmer B, Greinert R. UVA-induced epigenetic regulation of P16(INK4a) in human epidermal keratinocytes and skin tumor derived cells. Photochem Photobiol Sci 2012;11:180-90. [PMID: 21986889 DOI: 10.1039/c1pp05197k] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
168 Marcuzzi GP, Hufbauer M, Kasper HU, Weißenborn SJ, Smola S, Pfister H. Spontaneous tumour development in human papillomavirus type 8 E6 transgenic mice and rapid induction by UV-light exposure and wounding. J Gen Virol 2009;90:2855-64. [PMID: 19692543 DOI: 10.1099/vir.0.012872-0] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 5.9] [Reference Citation Analysis]
169 Verma RK, Yu W, Singh SP, Shankar S, Srivastava RK. Anthothecol-encapsulated PLGA nanoparticles inhibit pancreatic cancer stem cell growth by modulating sonic hedgehog pathway. Nanomedicine. 2015;11:2061-2070. [PMID: 26199979 DOI: 10.1016/j.nano.2015.07.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 5.1] [Reference Citation Analysis]
170 Lozzi F, Lanna C, Mazzeo M, Garofalo V, Palumbo V, Mazzilli S, Diluvio L, Terrinoni A, Bianchi L, Campione E. Investigational drugs currently in phase II clinical trials for actinic keratosis. Expert Opin Investig Drugs 2019;28:629-42. [PMID: 31232099 DOI: 10.1080/13543784.2019.1636030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
171 Oberholzer PA, Kee D, Dziunycz P, Sucker A, Kamsukom N, Jones R, Roden C, Chalk CJ, Ardlie K, Palescandolo E, Piris A, MacConaill LE, Robert C, Hofbauer GF, McArthur GA, Schadendorf D, Garraway LA. RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors. J Clin Oncol 2012;30:316-21. [PMID: 22067401 DOI: 10.1200/JCO.2011.36.7680] [Cited by in Crossref: 285] [Cited by in F6Publishing: 121] [Article Influence: 25.9] [Reference Citation Analysis]
172 Di Nardo L, Pellegrini C, Di Stefani A, Del Regno L, Sollena P, Piccerillo A, Longo C, Garbe C, Fargnoli MC, Peris K. Molecular genetics of cutaneous squamous cell carcinoma: perspective for treatment strategies. J Eur Acad Dermatol Venereol 2020;34:932-41. [PMID: 31747091 DOI: 10.1111/jdv.16098] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
173 Nissinen L, Farshchian M, Riihilä P, Kähäri VM. New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma. Cell Tissue Res 2016;365:691-702. [PMID: 27411692 DOI: 10.1007/s00441-016-2457-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
174 Rundhaug JE, Mikulec C, Pavone A, Fischer SM. A role for cyclooxygenase-2 in ultraviolet light-induced skin carcinogenesis. Mol Carcinog 2007;46:692-8. [DOI: 10.1002/mc.20329] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 4.6] [Reference Citation Analysis]
175 Campione E, Ventura A, Diluvio L, Mazzeo M, Mazzilli S, Garofalo V, Di Prete M, Bianchi L. Current developments in pharmacotherapy for actinic keratosis. Expert Opin Pharmacother 2018;19:1693-704. [PMID: 30222011 DOI: 10.1080/14656566.2018.1523896] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
176 Panelos J, Tarantini F, Paglierani M, Di Serio C, Maio V, Pellerito S, Pimpinelli N, Santucci M, Massi D. Photoexposition discriminates Notch 1 expression in human cutaneous squamous cell carcinoma. Mod Pathol 2008;21:316-25. [PMID: 18192969 DOI: 10.1038/modpathol.3801007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
177 Bruegger C, Kempf W, Spoerri I, Arnold AW, Itin PH, Burger B. MicroRNA expression differs in cutaneous squamous cell carcinomas and healthy skin of immunocompetent individuals. Exp Dermatol 2013;22:426-8. [PMID: 23711067 DOI: 10.1111/exd.12153] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
178 Antonsson A, Green AC, Mallitt KA, O'Rourke PK, Pandeya N, Pawlita M, Waterboer T, Neale RE. Prevalence and stability of antibodies to 37 human papillomavirus types--a population-based longitudinal study. Virology 2010;407:26-32. [PMID: 20723959 DOI: 10.1016/j.virol.2010.07.046] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
179 Patel GK, Yee CL, Yuspa SH, Vogel JC. A humanized stromal bed is required for engraftment of isolated human primary squamous cell carcinoma cells in immunocompromised mice. J Invest Dermatol 2012;132:284-90. [PMID: 21975825 DOI: 10.1038/jid.2011.284] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
180 Geusau A, Pohanka E. Aftercare – A Multi-disciplinary Approach. In: Stockfleth E, Ulrich C, editors. Skin Cancer after Organ Transplantation. Boston: Springer US; 2009. pp. 405-15. [DOI: 10.1007/978-0-387-78574-5_32] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
181 Ciani F, Tafuri S, Troiano A, Cimmino A, Fioretto BS, Guarino AM, Pollice A, Vivo M, Evidente A, Carotenuto D, Calabrò V. Anti-proliferative and pro-apoptotic effects of Uncaria tomentosa aqueous extract in squamous carcinoma cells. J Ethnopharmacol 2018;211:285-94. [PMID: 28964869 DOI: 10.1016/j.jep.2017.09.031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
182 Park EJ, Kim YM, Chang KC. Hemin Reduces HMGB1 Release by UVB in an AMPK/HO-1-dependent Pathway in Human Keratinocytes HaCaT Cells. Archives of Medical Research 2017;48:423-31. [DOI: 10.1016/j.arcmed.2017.10.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
183 Daya-grosjean L. Xeroderma Pigmentosum and Skin Cancer. In: Ahmad SI, Hanaoka F, editors. Molecular Mechanisms of Xeroderma Pigmentosum. New York: Springer; 2009. pp. 19-27. [DOI: 10.1007/978-0-387-09599-8_3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
184 Gomez Lira M, Mazzola S, Tessari G, Malerba G, Ortombina M, Naldi L, Remuzzi G, Boschiero L, Forni A, Rugiu C, Piaserico S, Girolomoni G, Turco A. Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation. Br J Dermatol 2007;157:49-57. [DOI: 10.1111/j.1365-2133.2007.07921.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
185 Youssef M, Cuddihy A, Darido C. Long-Lived Epidermal Cancer-Initiating Cells. Int J Mol Sci 2017;18:E1369. [PMID: 28654000 DOI: 10.3390/ijms18071369] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
186 Perrem K, Lynch A, Al Nooh F, Leader M, Elaine Kay. The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population. Hum Pathol 2008;39:1034-41. [PMID: 18482746 DOI: 10.1016/j.humpath.2007.11.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
187 Geusau A, Dunkler D, Messeritsch E, Sandor N, Heidler G, Rödler S, Ankersmit J, Zuckermann A, Tschachler E. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy. International Journal of Dermatology 2008;47:918-25. [DOI: 10.1111/j.1365-4632.2008.03711.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
188 Boeckmann L, Martens MC, Emmert S. Molecular Biology of Basal and Squamous Cell Carcinomas. Adv Exp Med Biol 2020;1268:171-91. [PMID: 32918219 DOI: 10.1007/978-3-030-46227-7_9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
189 Lee S, Rodriguez-Villanueva J, McDonnell T. Restrained Terminal Differentiation and Sustained Stemness in Neonatal Skin by Ha-Ras and Bcl-2. Am J Dermatopathol 2017;39:199-203. [PMID: 27655119 DOI: 10.1097/DAD.0000000000000678] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
190 Dotto GP. Calcineurin signaling as a negative determinant of keratinocyte cancer stem cell potential and carcinogenesis. Cancer Res. 2011;71:2029-2033. [PMID: 21406393 DOI: 10.1158/0008-5472.CAN-10-3750] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
191 Hortlund M, Arroyo Mühr LS, Storm H, Engholm G, Dillner J, Bzhalava D. Cancer risks after solid organ transplantation and after long-term dialysis. Int J Cancer 2017;140:1091-101. [PMID: 27870055 DOI: 10.1002/ijc.30531] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 8.0] [Reference Citation Analysis]
192 Hultin E, Arroyo Mühr LS, Lagheden C, Dillner J. HPV transcription in skin tumors. PLoS One 2019;14:e0217942. [PMID: 31150522 DOI: 10.1371/journal.pone.0217942] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
193 Bhandari PR, Pai VV. Novel medical strategies combating nonmelanoma skin cancer. Indian J Dermatol 2014;59:531-46. [PMID: 25484380 DOI: 10.4103/0019-5154.143503] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
194 Campione E, Paternò EJ, Candi E, Falconi M, Costanza G, Diluvio L, Terrinoni A, Bianchi L, Orlandi A. The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors. Drug Des Devel Ther 2015;9:5843-50. [PMID: 26604686 DOI: 10.2147/DDDT.S84849] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
195 Dasari S, Yedjou CG, Brodell RT, Cruse AR, Tchounwou PB. Therapeutic strategies and potential implications of silver nanoparticles in the management of skin cancer. Nanotechnol Rev 2020;9:1500-21. [PMID: 33912377 DOI: 10.1515/ntrev-2020-0117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
196 Martinez MAR, Francisco G, Cabral LS, Ruiz IRG, Festa Neto C. Genética molecular aplicada ao câncer cutâneo não melanoma. An Bras Dermatol 2006;81:405-19. [DOI: 10.1590/s0365-05962006000500003] [Cited by in Crossref: 15] [Article Influence: 0.9] [Reference Citation Analysis]
197 Cantariño N, Fernández-Figueras MT, Valero V, Musulén E, Malinverni R, Granada I, Goldie SJ, Martín-Caballero J, Douet J, Forcales SV, Buschbeck M. A cellular model reflecting the phenotypic heterogeneity of mutant HRAS driven squamous cell carcinoma. Int J Cancer 2016;139:1106-16. [PMID: 27074337 DOI: 10.1002/ijc.30139] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
198 Dhabhar FS, Saul AN, Daugherty C, Holmes TH, Bouley DM, Oberyszyn TM. Short-term stress enhances cellular immunity and increases early resistance to squamous cell carcinoma. Brain Behav Immun 2010;24:127-37. [PMID: 19765644 DOI: 10.1016/j.bbi.2009.09.004] [Cited by in Crossref: 69] [Cited by in F6Publishing: 57] [Article Influence: 5.3] [Reference Citation Analysis]
199 Hudson LG, Gale JM, Padilla RS, Pickett G, Alexander BE, Wang J, Kusewitt DF. Microarray analysis of cutaneous squamous cell carcinomas reveals enhanced expression of epidermal differentiation complex genes. Mol Carcinog 2010;49:619-29. [PMID: 20564339 DOI: 10.1002/mc.20636] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
200 Lewis W, Simanyi E, Li H, Thompson CA, Nasti TH, Jaleel T, Xu H, Yusuf N. Regulation of ultraviolet radiation induced cutaneous photoimmunosuppression by toll-like receptor-4. Arch Biochem Biophys 2011;508:171-7. [PMID: 21236239 DOI: 10.1016/j.abb.2011.01.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
201 Rangwala S, Tsai KY. Roles of the immune system in skin cancer. Br J Dermatol 2011;165:953-65. [PMID: 21729024 DOI: 10.1111/j.1365-2133.2011.10507.x] [Cited by in Crossref: 103] [Cited by in F6Publishing: 90] [Article Influence: 10.3] [Reference Citation Analysis]
202 Nindl I, Gottschling M, Krawtchenko N, Lehmann MD, Röwert-Huber J, Eberle J, Stockfleth E, Forschner T. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis. Br J Dermatol 2007;156 Suppl 3:34-9. [PMID: 17488404 DOI: 10.1111/j.1365-2133.2007.07857.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
203 Küsters-Vandevelde HV, Van Leeuwen A, Verdijk MA, de Koning MN, Quint WG, Melchers WJ, Ligtenberg MJ, Blokx WA. CDKN2A but not TP53 mutations nor HPV presence predict poor outcome in metastatic squamous cell carcinoma of the skin. Int J Cancer 2010;126:2123-32. [PMID: 19739123 DOI: 10.1002/ijc.24871] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
204 Mauerer A, Herschberger E, Dietmaier W, Landthaler M, Hafner C. Low incidence of EGFR and HRAS mutations in cutaneous squamous cell carcinomas of a German cohort. Exp Dermatol 2011;20:848-50. [PMID: 21771097 DOI: 10.1111/j.1600-0625.2011.01334.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
205 Pons M, Quintanilla M. Molecular biology of malignant melanoma and other cutaneous tumors. Clin Transl Oncol 2006;8:466-74. [PMID: 16870533 DOI: 10.1007/s12094-006-0046-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]